AgenT Company
AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.
.png)
Last Funding Type:
Seed
Funding Status:
Seed
Headquarters:
Paris, Ile-de-France, France
Founded Date:
2018-03-16
Investor Type:
N/A
Investment Stage:
N/A
Last Funding Date:
2021-07-01
Total Funding:
3944995.0
Technology:
Neuropharmacology
Employee Number:
1-10
Number Of Exists:
N/A
Investors Number:
2.0
Industry:
Biotechnology, Health Care, Health Diagnostics, Life Science, Neuroscience